Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Dagan

Showing results (1-10 of 367) with videos related to

Pageof 37
Sort By:
Human Vaccines & Immunotherapeutics|February 25, 2016
The diversity of pneumococcal conjugate vaccine impact observed through their implementationRon Dagan
Current Opinion in Otolaryngology & Head and Neck Surgery|November 19, 2004
The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology: the case of acute otitis mediaRon Dagan
Vaccine|June 26, 2009
New insights on pneumococcal disease: what we have learned over the past decadeRon Dagan
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 4, 2003
Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principlesRon Dagan
Paediatric Drugs|July 2, 2010
Appropriate treatment of acute otitis media in the era of antibiotic resistanceRon Dagan
Advances in Experimental Medicine and Biology|March 14, 2009
Pneumococcal conjugate vaccines probe studies: the solution points to the problemRon Dagan
International Journal of Antimicrobial Agents|November 6, 2007
The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis mediaRon Dagan
Vaccine|September 20, 2008
The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?Ron Dagan
Vaccine|September 8, 2011
Childhood pneumococcal disease in Latin America: preventable but still deadlyRon Dagan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2008
Use of pneumococcal conjugate vaccine to decrease rates of bacterial meningitisRon Dagan
Pageof 37

Showing results (1-10 of 367) with videos related to

Sort By:
Pageof 37
Human Vaccines & Immunotherapeutics|February 25, 2016
The diversity of pneumococcal conjugate vaccine impact observed through their implementationRon Dagan
Current Opinion in Otolaryngology & Head and Neck Surgery|November 19, 2004
The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology: the case of acute otitis mediaRon Dagan
Vaccine|June 26, 2009
New insights on pneumococcal disease: what we have learned over the past decadeRon Dagan
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 4, 2003
Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principlesRon Dagan
Paediatric Drugs|July 2, 2010
Appropriate treatment of acute otitis media in the era of antibiotic resistanceRon Dagan
Advances in Experimental Medicine and Biology|March 14, 2009
Pneumococcal conjugate vaccines probe studies: the solution points to the problemRon Dagan
International Journal of Antimicrobial Agents|November 6, 2007
The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis mediaRon Dagan
Vaccine|September 20, 2008
The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?Ron Dagan
Vaccine|September 8, 2011
Childhood pneumococcal disease in Latin America: preventable but still deadlyRon Dagan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2008
Use of pneumococcal conjugate vaccine to decrease rates of bacterial meningitisRon Dagan
Pageof 37